Literature DB >> 12532044

Childhood bullous pemphigoid following hepatitis B immunization.

Zülal Erbagci1.   

Abstract

Bullous pemphigoid (BP) is an acquired autoimmune bullous disorder which predominantly affects the elderly. It is very rare in children. There are approximately 50 reported cases of childhood BP. Although the cause of childhood BP is unknown, drug intake and vaccination have been incriminated in some cases. A total of 13 patients with BP (10 adults and 3 infants) have been described to be related to various vaccines and tetanus toxoid booster. However, no case related to hepatitis B vaccination has previously been reported. Our case of childhood BP developed one week after hepatitis B immunization in a Turkish caucasian child. This case suggests that the hepatitis B surface antigen can function as the triggering factor for BP by inducing a nonspecific immune reactivation which unmasks subclinical BP or by stimulating a specific antibody production that may cross-react with BP antigens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12532044     DOI: 10.1111/j.1346-8138.2002.tb00223.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

Review 1.  Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.

Authors:  William F Pendergraft; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Mol Med (Berl)       Date:  2004-12-11       Impact factor: 4.599

Review 2.  Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection.

Authors:  Ioana Grigorescu; Dan Lucian Dumitrascu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

3.  Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine.

Authors:  Amar D Desai; Radhika Shah; Attiya Haroon; Cindy Wassef
Journal:  Cureus       Date:  2022-04-13

Review 4.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

5.  Three case reports of post immunization and post viral Bullous Pemphigoid: looking for the right trigger.

Authors:  Luca Baroero; Paola Coppo; Laura Bertolino; Stefano Maccario; Francesco Savino
Journal:  BMC Pediatr       Date:  2017-02-23       Impact factor: 2.125

Review 6.  Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.

Authors:  Javier Antoñanzas; Nuria Rodríguez-Garijo; Ángela Estenaga; Ana Morelló-Vicente; Agustín España; Leyre Aguado
Journal:  Dermatol Ther       Date:  2022-07-20       Impact factor: 3.858

Review 7.  Clinical relevance of autoantibodies in patients with autoimmune bullous dermatosis.

Authors:  Lilla Mihályi; Mária Kiss; Attila Dobozy; Lajos Kemény; Sándor Husz
Journal:  Clin Dev Immunol       Date:  2012-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.